Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked

Ítems similars

• Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection
  per: Huber, Michael, et al.
  Publicat: (2006)
• In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers
  per: Trkola, Alexandra, et al.
  Publicat: (2008)
• In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10
  per: Manrique, Amapola, et al.
  Publicat: (2007)
• Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)
  per: Joos, Beda, et al.
  Publicat: (2006)
• Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors
  per: Rusert, Peter, et al.
  Publicat: (2005)